蘇奧傳感(300507.SZ):擬向中創新航定增募資不超6.73億元
格隆匯5月6日丨蘇奧傳感(300507.SZ)公佈2025年度向特定對象發行A股股票預案,本次發行股票數量不超過119,482,337股。發行股票數量的上限未超過本次發行前公司總股本的30%。股票發行價格爲5.63元/股,不低於定價基準日之前20個交易日(不含定價基準日當日,下同)上市公司股票交易均價的80%。
本次發行的對象爲中創新航,其以現金認購本次發行的股票,中創新航已經與公司簽署了《附條件生效的股份認購合同》。
本次向特定對象發行A股股票募集資金總額不超過6.73億元,募集資金在扣除發行費用後的募集資金淨額,擬用於AMB覆銅基板建設項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.